June 2021

Abbott India Limited is a subsidiary of Abbott Laboratories, USA, a global, iversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products. The company now employs approximately 70,000 people and markets its products in 130 countries worldwide.

Post : Assistant Manager - External Manufacturing (On Site)

Ajanta Pharma Limited, a specialty pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages in domestic and international markets. Ajanta operates 7 state-of-the-art manufacturing facilities in India and Mauritius. 2 of die facilities in India have been successfully approved by USFDA.

About the Institute

Researchers from the Miami University in Ohio have optimized a new technique that will allow scientists to evaluate how potential inhibitors work on antibiotic-resistant bacteria. This technique, called native state mass spectrometry, provides a quick way for scientists to identify the best candidates for effective clinical drugs, particularly in cases where bacteria can no longer be treated with antibiotics alone. This research will be presented at the American Society for Microbiology World Microbe Forum online conference on June 21, 2021.

Cells contain machinery that duplicates DNA into a new set that goes into a newly formed cell. That same class of machines, called polymerases, also build RNA messages, which are like notes copied from the central DNA repository of recipes, so they can be read more efficiently into proteins. But polymerases were thought to only work in one direction DNA into DNA or RNA. This prevents RNA messages from being rewritten back into the master recipe book of genomic DNA.

The Council for Scientific and Industrial Research (CSIR), and Tata Medical and Diagnostics Ltd (Tata MD), the new healthcare venture from the Tata Group have teamed up to boost the COVID-19 testing capacity across Tier-II and Tier-III towns as well as rural areas, across India. The two organisations are developing capacity to handle any future surge in the COVID-19 testing requirements.

Todays approval provides an important new treatment option which can now help the millions of people in Europe living with symptomatic chronic heart failure with reduced ejection fraction said Faiez Zannad, M.D., Ph.D., EMPEROR Program clinical investigator and Emeritus Professor of Therapeutics at the University of Lorraine, France. New treatment options such as empagliflozin can save lives and help people spend less time in the hospital and more time with their families.

CSIR-Central Drug Research Institute, Lucknow is a constituent laboratory under Council of Scientific and Industrial Research (CSIR), New Delhi.  It is a unique R&D Institution in the country with state-of-the-art infrastructure for fundamental chemical and biomedical research driven new drug discovery and development. Institute is richly contributing to the advancement of understanding of disease biology in the areas of national priorities, and set-off revolution of Indian pharma sector over the past 70 years.

National Health Mission Jalgaon City Municipal Corporation, Jalgaon The following posts are to be filled on temporary basis on contract basis.

Post: Pharmacist